Cardiovascular protection of diabetics: in the heart of evidence

Organized with the support of novo nordisk

Jeudi 18 Janvier 2018   12:30-13:30   242 AB room
Lunch debate (organized with the participation of Industry)
Cardiovascular protection of high-risk cardiovascular patients: the triumph of evidence-based medicine
12:45 • Ronan Roussel
R-GLP-1 agonists: from pharmacodynamic properties to therapeutic strategy
13:00 • Nicolas Danchin
Clinical cardiovascular impact
13:15
Questions & Answers